Search Results 421-430 of 16821 for Antagonist

1. Publications - Jonathan M. Wong, M.D. - Mayo Clinic

   Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152). J ...

2. Metastatic castration-resistant prostate cancer (mCRPC) - Diagnosis and treatment - Mayo Clinic

   ... antagonists. Another name for them is gonadotropin-releasing hormone (GnRH) agonists and antagonists. Medicines that work in this way include degarelix ...

3. Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism - Mayo Clinic

   -Chronic treatment with a vitamin K antagonist, or known coagulopathy including severe hepatic dysfunction, with an International Normalized Ratio (INR) > 1.5 - ...

4. A Study to Analyze the Effect of Obesity on Eosinophil (disease fighting white blood cell) Recruitment in Human Adipose Tissue - Mayo Clinic

   Subjects will also not be taking any leukotriene receptor antagonist acting medications (ex. Montelukast). All subjects will be self reported non-smokers ...

5. A Study of Treatment with Docetaxel and Prednisone, with or without Vaccine Therapy, for Patients who have Metastatic Hormone-Resistant Prostate Cancer - Mayo Clinic

   ... antagonist treatment); If receiving GnRH analogue or antagonist must continue this treatment throughout the time on this study; Must have been treated ...

6. Alisertib in Treating Patients With Advanced or Metastatic Sarcoma - Mayo Clinic

   ... antagonist, or pancreatic enzymes; note: intermittent uses of antacids or H2 antagonists are allowed; Inability to swallow oral medication or to maintain a ...

7. A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors - Mayo Clinic

   ... antagonist, with properties that support its continued clinical investigation in patients with cancer. Read More on PubMed. Additional contact information.

8. Tradipitant After GLP-1R Agonist In Healthy, Overweight, or Class I or II Obese Volunteers - Mayo Clinic

   Use of the following within 2 weeks of screening: an other GLP-1 agonist, an NK-1 antagonist or a second generation 5-HT3 antagonist, amylin analogs (e.g. ...

9. A Study of Ubenimex in Patients with Pulmonary Arterial Hypertension - Mayo Clinic

   On stable dose of at least one of the following PAH-specific therapies. Endothelin receptor antagonist; An agent acting on the nitric oxide pathway ...

10. Heart Attack Clinical Trials - Mayo Clinic Research

    The purpose of this study is to determine if apixaban given for 6 months is safer than Vitamin K Antagonist (VKA) given for 6 months in terms of major ...